186 related articles for article (PubMed ID: 32947757)
1. Nonalcoholic fatty liver disease in males with low testosterone concentrations.
Polyzos SA; Mousiolis A; Mintziori G; Goulis DG
Diabetes Metab Syndr; 2020; 14(5):1571-1577. PubMed ID: 32947757
[TBL] [Abstract][Full Text] [Related]
2. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
Mikolasevic I; Domislovic V; Krznaric-Zrnic I; Krznaric Z; Virovic-Jukic L; Stojsavljevic S; Grgurevic I; Milic S; Vukoja I; Puz P; Aralica M; Hauser G
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208576
[No Abstract] [Full Text] [Related]
3. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
4. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.
Singh A; Le P; Lopez R; Alkhouri N
Hepatol Int; 2018 Jan; 12(1):37-43. PubMed ID: 29318450
[TBL] [Abstract][Full Text] [Related]
5. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
Behari J; Bradley A; Townsend K; Becich MJ; Cappella N; Chuang CH; Fernandez SA; Ford DE; Kirchner HL; Morgan R; Paranjape A; Silverstein JC; Williams DA; Donahoo WT; Asrani SK; Ntanios F; Ateya M; Hegeman-Dingle R; McLeod E; McTigue K
Dig Dis Sci; 2024 Feb; 69(2):370-383. PubMed ID: 38060170
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus.
Caretta N; Scafa R; Graziani A; Crepaldi MC; Vedovato M; Avogaro A; Ferlin A
J Clin Endocrinol Metab; 2024 Jan; 109(2):e522-e530. PubMed ID: 37795977
[TBL] [Abstract][Full Text] [Related]
7. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.
Fujihara Y; Hamanoue N; Yano H; Tanabe M; Akehi Y; Nomiyama T; Yanase T
Endocr J; 2019 Jul; 66(7):637-645. PubMed ID: 31068503
[TBL] [Abstract][Full Text] [Related]
8. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
Corbin KD; Pittas AG; Desouza C; Grdinovac KK; Herzig KH; Kashyap SR; Kim SH; Nelson J; Rasouli N; Vickery EM; Knowler WC; Pratley RE
J Diabetes Complications; 2023 Jun; 37(6):108475. PubMed ID: 37104979
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
[TBL] [Abstract][Full Text] [Related]
11. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
12. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus.
Makri E; Kita M; Goulas A; Papaioannidou P; Efstathiadou ZA; Adamidou F; Polyzos SA
Diabetes Metab Syndr; 2020; 14(6):1913-1919. PubMed ID: 33011499
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
Song DS; Chang UI; Kang SG; Song SW; Yang JM
Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
[TBL] [Abstract][Full Text] [Related]
16. Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
Dayton KA; Bril F; Barb D; Lai J; Kalavalapalli S; Cusi K
PLoS One; 2021; 16(6):e0251449. PubMed ID: 34077443
[TBL] [Abstract][Full Text] [Related]
17. Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.
Vachliotis ID; Vasiloglou MF; Kapama A; Matsagkos D; Goulas A; Papaioannidou P; Polyzos SA
Arab J Gastroenterol; 2022 Nov; 23(4):277-287. PubMed ID: 35927197
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease.
Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N
J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
